CA Stock MarketDetailed Quotes
ASEP ASEP Medical Holdings Inc
- 0.050
- -0.010-16.67%
15min DelayMarket Closed Nov 22 11:41 ET
3.82MMarket Cap-625P/E (TTM)
0.050High0.050Low6.00KVolume0.050Open0.060Pre Close300.00Turnover0.32052wk High0.01%Turnover Ratio76.31MShares0.03552wk Low-0.08EPS TTM2.89MFloat Cap1.030Historical HighLossP/E (Static)57.72MShs Float0.035Historical Low-0.13EPS LYR0.00%Amplitude--Dividend TTM0.34P/B1Lot Size--Div YieldTTM
ASEP Medical Holdings Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 84.25%-106.65K | 75.68%-140.67K | 24.95%-2.71M | 48.34%-788.92K | -388.60%-668.16K | 28.91%-677.1K | 42.05%-578.42K | -203.47%-3.61M | -476.99%-1.53M | -136.75K |
| Net income from continuing operations | 52.43%-1.33M | 58.29%-933.46K | -63.80%-9.43M | -47.65%-2.28M | -83.86%-2.11M | -86.19%-2.81M | -43.39%-2.24M | -145.66%-5.76M | -36.35%-1.54M | ---1.15M |
| Operating gains losses | --13.29K | --14.37K | --429.86K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 1.91%326.75K | 2.07%327.25K | 0.93%1.29M | 2.10%327.23K | 1.66%325.8K | 0.16%320.62K | -0.21%320.61K | 623.79%1.28M | 83.26%320.51K | --320.49K |
| Remuneration paid in stock | -33.77%331.97K | -75.52%80.88K | 74.44%1.95M | 30.79%221.48K | 386.42%898.92K | 79.92%501.23K | -32.06%330.42K | 17.03%1.12M | --169.33K | --184.8K |
| Deferred tax | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---89.1K | ---- | ---- |
| Other non cashItems | -103.98%-28.36K | -104.91%-28.38K | 454.36%1.39M | ---553 | --98.32K | --713.23K | --578.14K | 228.04%250.58K | ---- | ---- |
| Change In working capital | -1.57%584.62K | -7.38%398.68K | 493.35%1.65M | 180.28%510.59K | -76.70%117.64K | 1,448.64%593.95K | 275.69%430.42K | -31.30%-420.14K | -84.39%-636.01K | --504.9K |
| -Change in receivables | -146.34%-6.19K | -108.94%-8.02K | 316.39%89.2K | 212.43%14.7K | -264.60%-12.78K | 82.97%-2.51K | 1,008.05%89.79K | 43.84%-41.22K | 45.10%-13.08K | ---3.51K |
| -Change in prepaid assets | -83.61%57.36K | -99.56%1.59K | 230.14%992.84K | 124.90%46.14K | 213.32%239.12K | 277.77%349.88K | 310.72%357.71K | -95.23%-762.88K | 52.38%-185.31K | ---211.01K |
| -Change in payables and accrued expense | 116.33%533.45K | 2,472.26%405.11K | 48.60%570.57K | 202.77%449.75K | -115.11%-108.7K | 47.20%246.59K | 73.87%-17.08K | 166.33%383.96K | -742.94%-437.62K | --719.41K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 84.25%-106.65K | 75.68%-140.67K | 24.95%-2.71M | 48.34%-788.92K | -388.60%-668.16K | 28.91%-677.1K | 42.05%-578.42K | -203.47%-3.61M | -476.99%-1.53M | ---136.75K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 81.09%-190 | 84.52%-190 | -103.58%-4.47K | -100.70%-870 | -1.37K | -1.01K | -1.23K | -14.57%124.8K | -89.45%124.8K | 0 |
| Net PPE purchase and sale | --0 | --0 | ---1.23K | --0 | --0 | --0 | ---1.23K | --0 | --0 | --0 |
| Net intangibles purchas and sale | 81.09%-190 | ---190 | -645.75%-3.24K | -100.00%-870 | ---1.37K | ---1.01K | --0 | ---435 | -101.49%-435 | --0 |
| Net business purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -52.17%125.23K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 81.09%-190 | 84.52%-190 | -103.58%-4.47K | -100.70%-870 | ---1.37K | ---1.01K | ---1.23K | -14.57%124.8K | -89.45%124.8K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 113.47K | 94.8K | 97.39%651.4K | 79.21%591.4K | 60K | 0 | 0 | -94.79%330K | -92.48%330K | |
| Net issuance payments of debt | ---- | ---- | -93.94%20K | ---- | ---- | ---- | ---- | -34.00%330K | ---- | ---- |
| Net common stock issuance | ---- | ---- | --587K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | --60K | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
| Net other financing activities | --113.47K | --94.8K | ---15.6K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --113.47K | --94.8K | 97.39%651.4K | 79.21%591.4K | --60K | --0 | --0 | -94.79%330K | -92.48%330K | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -98.80%18.66K | -96.96%64.72K | -59.73%2.13M | -91.78%263.12K | -73.87%872.64K | -63.87%1.55M | -59.73%2.13M | --5.29M | 832.46%3.2M | --3.34M |
| Current changes in cash | 100.98%6.64K | 92.05%-46.06K | 34.62%-2.07M | 81.50%-198.39K | -345.72%-609.52K | 28.80%-678.1K | 41.93%-579.65K | -159.73%-3.16M | -120.21%-1.07M | ---136.75K |
| End cash Position | -97.10%25.3K | -98.80%18.66K | -96.96%64.72K | -96.96%64.72K | -91.78%263.12K | -73.87%872.64K | -63.87%1.55M | -59.73%2.13M | -59.73%2.13M | --3.2M |
| Free cash from | 84.24%-106.84K | 75.70%-140.86K | 24.84%-2.72M | 48.30%-789.79K | -389.60%-669.52K | 28.80%-678.1K | 41.93%-579.65K | -176.63%-3.61M | -340.20%-1.53M | ---136.75K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data